Mesothelioma clinical trials allow patients to try new or experimental treatments. These clinical studies recruit patients for cutting-edge therapies such as mesothelioma vaccines, gene therapy and other emerging treatments.
"Most helpful, steered us in the right direction for treatment. Great source of information and support, the Center followed through on every one of our requests...." see more
Elaine C.
Mesothelioma Patient
"Because of their guidance, I was able to navigate getting my mother into MD Anderson when her case got put aside by mistake in all the COVID-19 craziness. Vanes...." see more
Deanna B.
Daughter of a Mesothelioma Patient
"Hearing the news about my mother's diagnosis was heartbreaking. I felt lost, I didn't know how I could help or where to seek the best medical care. I started re...." see more
Danielle W.
Daughter of a Mesothelioma Patient
"My son Carlos was diagnosed with this terrible and unknown disease a few months ago. Thank God we found The Mesothelioma Center along the way, and Vanessa Blanc...." see more
Martha M.
Mother of a Mesothelioma Patient
"Extremely communicative and helped my dad get an appointment with one of the top centers in Philadelphia. I'm so grateful for this center. They assisted with in...." see more
Sunni H.
Loved One of a Mesothelioma Patient
"Danielle DiPietro was an invaluable resource for me. Her suggestions and recommendations guided us towards stellar practitioners in our area. Without her advoca...." see more
Deborah C.
Spouse of a Mesothelioma Patient
"I was very grateful and appreciative of Dr. Smart from The Mesothelioma Center. She was very helpful to my husband and me. She educated and walked us through th...." see more
Kimberlin C.
Spouse of a Mesothelioma Patient
"In January of 2016, my husband was diagnosed with peritoneal mesothelioma. Our first reaction was: what is this and what can we do? He was diagnosed by an oncol...." see more
Mesothelioma clinical trials are specialized research programs that test new therapies for safety and effectiveness. Researchers use clinical trials to investigate treatment benefits, improve screening and diagnosis methods, and uncover new disease prevention methods.
Types of Mesothelioma Clinical Trials
Prevention Trials: Cancer prevention trials study ways to reduce cancer risk through lifestyle changes or certain medications.
Screening Trials: These studies look for better methods of finding cancer earlier in patients, giving them more treatment options at diagnosis.
Treatment Trials: Mesothelioma clinical treatment trials examine the safety and effectiveness of new drugs, drug combinations and procedures.
Cancer research trials can last several months to years and go through many phases. Once recruitment starts, enrollment may be paused or canceled. During these checkpoints, researchers analyze the data. If the benefits don’t outweigh the risks of treatment, the study sponsor may suspend or terminate the study early.
Key Facts About Mesothelioma Clinical Trials
There are more than 70 clinical trials actively recruiting mesothelioma patients in the U.S.
In our 2023 survey, only 14% of respondents said they participated in a clinical trial.
Clinical trials led to the FDA approval of mesothelioma immunotherapies.
Many trials are available in dozens of locations across the country.
As of early 2024, more than 70 clinical trials across the U.S. are recruiting patients with mesothelioma malignancy. Our Patient Advocates at The Mesothelioma Center can help match you with clinical trials based on your diagnosis and where you live.
Active Mesothelioma Clinical Trials
Clinical Trial
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
This study examines whether intraperitoneal or intravenous chemotherapy given after cytoreductive surgery and HIPEC are effective treatments for peritoneal mesothelioma.
Condition: Peritoneal Mesothelioma
Intervention: Pemetrexed, Cisplatin, Carboplatin
Locations: New York, New York
Recruiting: September 2023 – Present
Clinical Trial
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
This first-in-human trial is designed to assess the safety, feasibility and potential activity of a single IV dose of SynKIR-110 administered to subjects with mesothelin-expressing advanced ovarian cancer, mesothelioma and cholangiocarcinoma.
Condition: Malignant Mesothelioma
Intervention: Immunotherapy
Locations: Philadelphia, Pennsylvania
Recruiting: April 2023 – Present
Clinical Trial
A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
The purpose of this study is to characterize the safety and tolerability of IAG933 in patients with mesothelioma, NF2/LATS1/LATS2 mutated tumors and tumors with functional YAP/TAZ fusions and to identify the maximum tolerated dose and/or recommended dose.
Condition: Malignant Mesothelioma
Intervention: Immunotherapy
Locations: Boston, Massachusetts
Recruiting: March 2023 – Present
Clinical Trial
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma
Patients in this study receive immunotherapy with standard chemotherapy in a surgical treatment plan.
Condition: Pleural Mesothelioma
Intervention: Immunotherapy
Locations: Philadelphia, Pennsylvania
Recruiting: January 2023 – Present
Clinical Trial
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
This phase 2 trial compares the usual treatment alone to using immunotherapy plus the usual treatment in treating patients with peritoneal mesothelioma.
Condition: Peritoneal Mesothelioma
Intervention: Atezolizumab, Bevacizumab
Locations: Chicago, Illinois
Recruiting: March 2022 – Present
Clinical Trial
Mesothelin-Targeted CAR T-Cell Therapy in Patients with Mesothelioma
This study tests the safety of MSLN-targeted CAR T-cells to find the safest dose to give to people with malignant pleural mesothelioma. It is the first study of its kind in people.
Condition: Pleural Mesothelioma
Intervention: CAR T-Cell Therapy
Locations: New York, New York
Recruiting: October 2020 – Present
Clinical Trial
Poly-ICLC (Hiltonol) Vaccine in Malignant Pleural Mesothelioma
This study examines the safety and effectiveness of poly-ICLC directly injected into malignant pleural mesothelioma during biopsy before the surgical removal.
Condition: Pleural Mesothelioma
Intervention: Poly-ICLC (Hiltonol) Vaccine
Locations: New York, New York
Recruiting: August 2020 – Present
Clinical Trial
Olaparib in Patients With HRD Malignant Mesothelioma
In this study, researchers will give olaparib to mesothelioma patients who have specific changes in their DNA (known as gene mutations).
Condition: Pleural Mesothelioma
Intervention: Olaparib
Locations: Chicago, Illinois
Recruiting: February 2021 – Present
Mesothelioma clinical trials span many treatment options, including emerging treatments such as gene therapy and vaccine therapy, advancements in immunotherapy, surgical procedures and new chemotherapy approaches. Testing new combinations of techniques helps researchers find new or improved methods of treating mesothelioma that offer significant benefits without substantial risk.
How Do I Enroll in a Clinical Trial for Mesothelioma?
You can enroll in a mesothelioma clinical trial with help from our Patient Advocates or your doctor. Mesothelioma specialists generally know which clinical trials their patients may be eligible to join. Cancer centers and clinics participating in research trials typically have staff dedicated to running clinical trials.
If you meet eligibility requirements, a research coordinator may contact you. Every mesothelioma clinical trial has specific criteria for who is eligible to participate. Some trials are only for patients who have yet to be treated or have metastatic disease, while others are for those who didn’t respond well to standard treatments.
Along with eligibility requirements, frequent blood and imaging tests are a standard part of clinical trials. These extra precautions ensure that you’re eligible for the study and that the experimental treatment won’t cause additional harm.
After you talk to your mesothelioma doctor or a Patient Advocate, take the time to determine the trials that most appeal to you. Review and discuss the research trial information with your family. Ask your doctor as many questions as necessary to understand the risks and benefits of the trial. Once you decide, your medical team will help you begin the screening process.
Find Active Mesothelioma Clinical Trials
Try our new clinical trials search tool to find active trials near you. Get help enrolling today.
How Mesothelioma Clinical Trials Can Help Patients
Mesothelioma patients may benefit from new emerging treatments or advanced approaches tested in clinical trials. Trials may help improve their prognosis and quality of life. These therapies may not be available through standard treatment options, making clinical trials a valuable resource for mesothelioma patients.
I want to be as helpful as I can. Being in a clinical trial has allowed me to do that, providing information to researchers about therapies that could help patients in the future. Sure, I was hoping it could help me, but it’s also rewarding when you know you’re helping others, which is what a clinical trial does.
Experimental drugs, for example, can provide a targeted approach to treating cancer. These drugs target specific proteins or pathways in cancer cells, attacking specific pathways involved in tumor growth and spread.
Clinical trials may offer patients the chance to receive a combination of experimental therapies. Some of these combinations have proven effective in early studies. This approach can be particularly beneficial for mesothelioma patients, as a multimodal therapeutic approach often yields the best outcomes when treating this cancer.
Survivor Story
Survivor Story
Ron GreenPleural Mesothelioma
Survivor Has Success With Two Clinical Trials
Ron Green spent almost a year in a clinical trial for the immunotherapy drug Keytruda. It’s shown impressive effectiveness, but only for a small percentage of patients. Green was one of the fortunate few. Some time after the trial, scans showed tumor regrowth despite the radiation therapy. He was referred to another trial for chemotherapy with anetumab ravtansine, which shrank his tumors.
Sometimes, a clinical trial results in a breakthrough, which can change the way doctors approach cancer treatment. For example, research studies led to FDA approval of the first mesothelioma chemotherapy option and the more recent Tumor-Treating Fields. The trial results that led to FDA approval showed improved overall survival over 6 months.
Although there is no cure for mesothelioma, successful clinical trial therapies improve survival rates and quality of life. Many mesothelioma trials struggle to get enough participants to test a new drug or treatment. Joining a trial helps researchers get closer to developing a cure for mesothelioma.
Sellas Life Sciences reports its Phase I clinical trial showed improvement of overall survival in patients with pleural mesothelioma. The study focused on…
Clinical trials always involve certain risks. The experimental treatment may not be as effective as anticipated, and you could experience unexpected side effects that harm your health.
Mesothelioma Clinical Trial Risks
Experimental Treatments: Researchers and clinical staff perform frequent testing and check-ins to minimize harm during the trial.
Travel to Trial Center: Clinical trials may not be available in your area, and travel may be difficult. Patient Advocates and treatment centers can arrange transportation for you.
Unknown Benefit: In some cases, experimental therapy may provide less benefit than traditional treatment. When this occurs, researchers quickly end the trial.
A mesothelioma clinical trial can last weeks, months or years, depending on the trial’s goal, the number of patients involved and the results. During this time, doctors and researchers work to maximize benefits and minimize risks. Clinical trials go through multiple phases to ensure a new treatment is safe and effective for a large population.
Get Help Paying for Treatment
Get help paying for mesothelioma treatment by accessing trust funds, grants and other options.
Getting answers to your questions to help you understand the details and purpose of the trial before enrolling is critical. Take notes during your meeting with your doctor.
Questions for Your Doctor
What is the specific goal of this trial?
Are there other treatment options I should consider first?
What are the costs?
What are the possible side effects?
Will I need to change my usual medications or routine?
Don’t be afraid to ask any questions you or your loved ones may have. Follow up with your doctor’s office or clinical trial staff if you think of other questions or need clarification to help you decide if participating in a clinical trial is best for you.
Common Questions About Mesothelioma Clinical Trials
How do I find out about mesothelioma clinical trials?
You can learn more about mesothelioma clinical trials from your doctor and at ClinicalTrials.gov. A Patient Advocate can also help you find available clinical trials that match your specific diagnosis.
Will I have to pay to participate in a mesothelioma clinical trial?
Many clinical trials cover all or part of the therapies used in clinical trials, but each trial varies. Health insurance often covers specific treatments, such as traditional chemotherapy.
Are placebos used in cancer clinical trials?
Placebos are not common, but they are sometimes used in cancer trials in combination with conventional treatment, experimental treatments or when no conventional treatment exists. Researchers are never allowed to withhold necessary medical care intentionally. Participating in a clinical trial will benefit you with high-quality medical care.
Can I withdraw from a mesothelioma clinical trial?
Yes, it’s always a patient’s right to withdraw from a clinical trial. Patients should provide “written informed consent” before participating in a clinical trial. The trial documentation should describe the right to cancel and how to withdraw. It may be most helpful for research if someone who withdraws from the trial treatment and tests continues to allow follow-up, for example, of side effects and length of life.
Answered By:Anna Nowak, internationally renowned asbestos researcher and mesothelioma advocate
Recommended Reading
Tell us what you think
Did this article help you?
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?
Thank you for your feedback. Would you like to speak with a Patient Advocate?
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
Who Am I Calling?
Calling this number connects you with a Patient Advocate at The Mesothelioma Center, the nation's most trusted mesothelioma resource.
Our Patient Advocates can help guide you or your loved one through the steps to take after a mesothelioma diagnosis. Our team has a combined experience of more than 30 years in assisting cancer patients, and includes a medical doctor, an oncology registered nurse and a U.S. Navy veteran.
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Reviewed
Asbestos.com is the nation’s most trusted mesothelioma resource
The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.
Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.
More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.
About The Mesothelioma Center at Asbestos.com
Assisting mesothelioma patients and their loved ones since 2006.
Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
A+ rating from the Better Business Bureau.
5-star reviewed mesothelioma and support organization.
My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family.
Marchese, S. (2024, October 21). Mesothelioma Clinical Trials. Asbestos.com. Retrieved October 21, 2024, from https://www.asbestos.com/treatment/clinical-trials/
MLA
Marchese, Sean. "Mesothelioma Clinical Trials." Asbestos.com, 21 Oct 2024, https://www.asbestos.com/treatment/clinical-trials/.
Chicago
Marchese, Sean. "Mesothelioma Clinical Trials." Asbestos.com. Last modified October 21, 2024. https://www.asbestos.com/treatment/clinical-trials/.
A medical doctor who specializes in mesothelioma or cancer treatment reviewed the content on this page to ensure it meets current medical standards and accuracy.
Please read our editorial guidelines to learn more about our content creation and review process.
Dr. Jacques Fontaine is a thoracic surgeon at Moffitt Cancer Center in Tampa, Florida, where he heads up the Mesothelioma Research and Treatment Center. He specializes in minimally invasive robotic surgery and aggressive surgeries for mesothelioma.
California Consumer Privacy Act (CCPA) Inquiries
Mesothelioma Center - Vital Services for Cancer Patients & Families doesn’t believe in selling customer information. However, as required by the new California Consumer Privacy Act (CCPA), you may record your preference to view or remove your personal information by completing the form below.